COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,189 Articles (22,713 medRxiv, 8,476 bioRxiv)

Most recent first Previous |  Page 1224: Articles 12231-12240  | Next

Toward Using Twitter Data to Monitor Covid-19 Vaccine Safety in Pregnancy
Klein, A. Z., O'Connor, K., Gonzalez-Hernandez, G.
10.1101/2021.09.15.21263653 — Posted: 2021-09-22
SARS-CoV-2 Delta variant of concern in Brazil - multiple introductions, communitary transmission, and early signs of local evolution
Patane, J., Viala, V., Lima, L., Martins, A., Barros, C., Marqueze, E., Bernardino, J., Moretti, D., Slavov, S., Bezerra, R., Rodrigues, E., Santos, E., Brassaloti, R., Cassano, R., Mariani, P., Kitajima, J., Santos, B., Assato, P., Costa, F., Poleti, M., Lesbon, J., Chicaroni, E., Banho, C., Sacchetto, L., Moraes, M., Palmieri, M., Vilanova, F., Grotto, R., Souza-Neto, J., Giovanetti, M., Alcantara, L., Nogueira, M., Fukumasu, H., Coutinho, L., Calado, R., Kashima, S., Machado, R., Covas, D., Elias, C., Coccuzzo, S.
10.1101/2021.09.15.21262846 — Posted: 2021-09-22
Childhood Asthma and COVID-19: A Nested Case-Control Study
Gaietto, K., Freeman, M. C., DiCicco, L. A., Rauenswinter, S., Squier, J. R., Aldewereld, Z., Iagnemma, J., Campfield, B. T., Wolfson, D., Kazmerski, T. M., Forno, E.
10.1101/2021.09.20.21263838 — Posted: 2021-09-22
Human Milk Antibodies Elicited by BNT162b2 Vaccination Target have reduced activity against SARS-CoV-2 Variants of Concern
Low, J. M., Gu, Y., Ng, M. S. F., Wang, L. W., Zubair, A., Zhong, Y., McAry, P.
10.1101/2021.09.20.21263808 — Posted: 2021-09-22
Health-care workers in gastrointestinal endoscopy are at higher risk for SARS-CoV-2 infection compared to other aerosol-generating disciplines
Roemmele, C., Ebigbo, A., Kahn, M., Zellmer, S., Muzalyova, A., Hammel, G., Bartenschlager, C., Beyer, A., Rosendahl, J., Schlittenbauer, T., Zenk, J., Al-Nawas, B., Frankenberger, R., Hoffmann, J., Arens, C., Lammert, F., Traidl-Hoffmann, C., Messmann, H.
10.1101/2021.09.20.21263566 — Posted: 2021-09-22
Health-Related Quality of Life and psychological distress of adolescents during the COVID-19 pandemic in Geneva
Dumont, R., Richard, V., Baysson, H., Lorthe, E., Piumatti, G., Schrempft, S., Wisniak, A., Barbe, R., Posfay Barbe, K., Guessous, I., Stringhini, S.
10.1101/2021.09.20.21263812 — Posted: 2021-09-22
Potential COVID-19 vaccination opportunities in primary care practices in the United States
Basu, S., Weintraub, R., Ganguli, I., Phillips, R., Phillips, R., Bitton, A.
10.1101/2021.09.20.21263757 — Posted: 2021-09-22
Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database
Tobaiqy, M., MacLure, K., Elkout, H., Stewart, D.
10.1101/2021.09.12.21263462 — Posted: 2021-09-22 Discussion: Onsite
Identifying At-Risk Communities and Key Vulnerability Indicators in the COVID-19 Pandemic
Thais, S., Leibowitz, S., Rios Gutierez, A., Passarelli, A., Santo, S., Shipp, N.
10.1101/2021.09.19.21263805 — Posted: 2021-09-22
The Delta Variant Had Negligible Impact on COVID-19 Vaccine Effectiveness in the USA
Blaiszik, B., Graziani, C., Olds, J. L., Foster, I.
10.1101/2021.09.18.21263783 — Posted: 2021-09-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).